DIAGNOSTIC VALIDITY OF CEA BLOOD-LEVELS IN METASTATIC BREAST-CANCER

被引：4

作者：

KRIEGER, G

PRANGEN, M

KLAR, R

KNEBA, M

BANDLOW, G

NAGEL, GA

机构：

[1] UNIV GOTTINGEN,MED INFORMAT ABT,D-3400 GOTTINGEN,FED REP GER

[2] UNIV GOTTINGEN,INST HYG,D-3400 GOTTINGEN,FED REP GER

[3] STADT KRANKENHAUS SEESEN,INNERE ABT,SEESEN,FED REP GER

来源：

KLINISCHE WOCHENSCHRIFT | 1986年 / 64卷 / 15期

关键词：

D O I：

10.1007/BF01712055

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：701 / 707

页数：7

共 28 条

[1]

ABEL U, 1983, TUMORDIAGN THER, V4, P39

[2]

BANDLOW G, 1978, ARZTL LAB, V24, P157

[3] MITOMYCIN-C AND HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN THE TREATMENT OF METASTATIC BREAST-CANCER - RESULTS OF A PHASE-II-STUDY OF THE AIO [J].

BARTSCH, HH ;

BLOSSEY, HC ;

NAGEL, GA .

ONKOLOGIE, 1982, 5 (05) :249-&

[4]

BONADONNA G, 1977, CANCER-AM CANCER SOC, V39, P2904, DOI 10.1002/1097-0142(197706)39:6<2904::AID-CNCR2820390677>3.0.CO

[5]

2-8

[6]

BUTTNER J, 1977, J CLIN CHEM CLIN BIO, V15, P1

[7]

FALKSON HC, 1978, CANCER, V42, P1308, DOI 10.1002/1097-0142(197809)42:3<1308::AID-CNCR2820420341>3.0.CO

[8]

2-N

[9]

HAAGENSEN DE, 1978, CANCER, V42, P1512, DOI 10.1002/1097-0142(197809)42:3+<1512::AID-CNCR2820420824>3.0.CO

[10]

2-6

← 1 2 3 →